JP2013518563A - ワクチンにおいて使用するための組換えタンパク質、前記タンパク質に対する抗体、ならびに該タンパク質を含む診断法および療法 - Google Patents

ワクチンにおいて使用するための組換えタンパク質、前記タンパク質に対する抗体、ならびに該タンパク質を含む診断法および療法 Download PDF

Info

Publication number
JP2013518563A
JP2013518563A JP2012551129A JP2012551129A JP2013518563A JP 2013518563 A JP2013518563 A JP 2013518563A JP 2012551129 A JP2012551129 A JP 2012551129A JP 2012551129 A JP2012551129 A JP 2012551129A JP 2013518563 A JP2013518563 A JP 2013518563A
Authority
JP
Japan
Prior art keywords
protein
seq
fragment
treponema
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012551129A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013518563A5 (OSRAM
Inventor
アンナ・ロサンデル
マリット・プリングル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2013518563A publication Critical patent/JP2013518563A/ja
Publication of JP2013518563A5 publication Critical patent/JP2013518563A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2012551129A 2010-01-28 2011-01-28 ワクチンにおいて使用するための組換えタンパク質、前記タンパク質に対する抗体、ならびに該タンパク質を含む診断法および療法 Pending JP2013518563A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US29896010P 2010-01-28 2010-01-28
US61/298,960 2010-01-28
US36098610P 2010-07-02 2010-07-02
US61/360,986 2010-07-02
PCT/SE2011/050090 WO2011093783A1 (en) 2010-01-28 2011-01-28 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same

Publications (2)

Publication Number Publication Date
JP2013518563A true JP2013518563A (ja) 2013-05-23
JP2013518563A5 JP2013518563A5 (OSRAM) 2014-03-13

Family

ID=44319584

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012551129A Pending JP2013518563A (ja) 2010-01-28 2011-01-28 ワクチンにおいて使用するための組換えタンパク質、前記タンパク質に対する抗体、ならびに該タンパク質を含む診断法および療法

Country Status (10)

Country Link
US (1) US8703432B2 (OSRAM)
EP (1) EP2528939B1 (OSRAM)
JP (1) JP2013518563A (OSRAM)
CN (1) CN102918053A (OSRAM)
AU (1) AU2011209988A1 (OSRAM)
BR (1) BR112012018840A2 (OSRAM)
CA (1) CA2825282A1 (OSRAM)
NZ (1) NZ601980A (OSRAM)
RU (1) RU2012137304A (OSRAM)
WO (1) WO2011093783A1 (OSRAM)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015002264A1 (ja) * 2013-07-03 2015-01-08 三菱化学フーズ株式会社 毛状疣贅病の予防および／または治療方法
KR102177180B1 (ko) * 2020-05-13 2020-11-10 순천대학교 산학협력단 신규 트레포네마 파지데니스 균주 및 이의 분리 방법
KR102177181B1 (ko) * 2020-05-14 2020-11-10 순천대학교 산학협력단 트레포네마 파지데니스 균주의 배양 조성물 및 이의 용도
JP2021503509A (ja) * 2017-11-17 2021-02-12 ヒプラ サイエンティフィック， エセ． エレ． ウ． 哺乳動物における趾皮膚炎に使用されるワクチン組成物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10010423B2 (en) 2013-03-15 2018-07-03 Avinash Kumar Anatomical humeral fixation system and method
US10022458B2 (en) 2015-03-05 2018-07-17 Iowa State University Research Foundation, Inc. Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06189773A (ja) * 1991-09-25 1994-07-12 Duphar Internatl Res Bv トレポネーマ・ヒオジセンテリエ ワクチン
JPH06292581A (ja) * 1991-10-25 1994-10-21 Duphar Internatl Res Bv トレポネーマ・ヒオジセンテリエ ワクチン
JP2002529063A (ja) * 1998-11-12 2002-09-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 乳頭腫症指皮膚炎（ｐｄｄ）に対するワクチン

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287575B1 (en) 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06189773A (ja) * 1991-09-25 1994-07-12 Duphar Internatl Res Bv トレポネーマ・ヒオジセンテリエ ワクチン
JPH06292581A (ja) * 1991-10-25 1994-10-21 Duphar Internatl Res Bv トレポネーマ・ヒオジセンテリエ ワクチン
JP2002529063A (ja) * 1998-11-12 2002-09-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 乳頭腫症指皮膚炎（ｐｄｄ）に対するワクチン

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6014033058; ＩＮＦＥＣＴＩＯＮ　ＡＮＤ　ＩＭＭＵＮＩＴＹ Ｖｏｌ．５９，　Ｎｏ．１０, 1991, ｐｐ．３６８５-３６９３ *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015002264A1 (ja) * 2013-07-03 2015-01-08 三菱化学フーズ株式会社 毛状疣贅病の予防および／または治療方法
JP5740062B1 (ja) * 2013-07-03 2015-06-24 三菱化学フーズ株式会社 毛状疣贅病の予防および／または治療方法
US9603827B2 (en) 2013-07-03 2017-03-28 Mitsubishi-Kagaku Foods Corporation Method for preventing and/or treating hairy wart disease
JP2021503509A (ja) * 2017-11-17 2021-02-12 ヒプラ サイエンティフィック， エセ． エレ． ウ． 哺乳動物における趾皮膚炎に使用されるワクチン組成物
JP7399865B2 (ja) 2017-11-17 2023-12-18 ヒプラ サイエンティフィック， エセ． エレ． ウ． 哺乳動物における趾皮膚炎に使用されるワクチン組成物
KR102177180B1 (ko) * 2020-05-13 2020-11-10 순천대학교 산학협력단 신규 트레포네마 파지데니스 균주 및 이의 분리 방법
KR102177181B1 (ko) * 2020-05-14 2020-11-10 순천대학교 산학협력단 트레포네마 파지데니스 균주의 배양 조성물 및 이의 용도

Also Published As

Publication number Publication date
AU2011209988A1 (en) 2012-09-13
BR112012018840A2 (pt) 2017-06-20
RU2012137304A (ru) 2014-03-10
CN102918053A (zh) 2013-02-06
US8703432B2 (en) 2014-04-22
EP2528939B1 (en) 2015-04-08
US20130034560A1 (en) 2013-02-07
EP2528939A4 (en) 2013-07-03
EP2528939A1 (en) 2012-12-05
WO2011093783A1 (en) 2011-08-04
NZ601980A (en) 2014-08-29
CA2825282A1 (en) 2011-08-04

Similar Documents

Publication Publication Date Title
US10682404B2 (en) Targets of Acinetobacter baumannii
JP2017503792A (ja) ＯｓｐＡの突然変異体断片、並びにそれに関する方法および使用
US10376570B2 (en) OmpA and ASP14 in vaccine compositions and as diagnostic targets
US8703432B2 (en) Recombinant Treponema spp. proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
AiHua et al. A sensitive and specific IgM-ELISA for the serological diagnosis of human leptospirosis using a rLipL32/1-LipL21-OmpL1/2 fusion protein
CN103819557A (zh) 一种阪崎肠杆菌OmpA多克隆抗体及其制备方法与应用
CN106008680A (zh) 一种链球菌保护性抗原sap及其制备方法
CN101981052B (zh) 组合物、方法及试剂盒
Bulashev et al. Immunogenicity and antigenicity of Brucella recombinant outer membrane proteins.
US10022458B2 (en) Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis
Rosander et al. Identification of immunogenic proteins in Treponema phagedenis-like strain V1 from digital dermatitis lesions by phage display
MX2010009516A (es) Secuencias novedosas de brachyspira, composiciones inmunogenicas, metodos para la preparacion y usos de las mismas.
Kastelic et al. Molecular characterisation of the Mycoplasma cynos haemagglutinin HapA
US20140248272A1 (en) Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
Yektaseresht et al. Cloning and Expression of Mannheimia haemolytica PlpE Gene in Escherichia coli and its Immunogenicity Assessment.
CA2606229A1 (en) Lawsonia intracellularis immunological proteins

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140123

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140123

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140804

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150106